Life sciences IP strategies will need to be revised significantly in the coming years to reflect technological, legal and political shifts, some of which have been accelerated by the extraordinary events of 2020.

IAM’s Pharma & Biotech IP Connect will bring together leading in-house practitioners and expert outside counsel to explore the most important IP trends impacting the industry. Discuss how IP professionals can best adapt their approaches to protecting and commercialising their clients’ innovations.

Sagacious IP, a global IP Research and Consulting firm and a WIPO GREEN Partner, together with IAM,  is hosting the launch event of the first ever report on the ‘Top Global Innovators Contributing to a Green Future & The State of Quality Patents in Green Tech’. 

The event will reveal a benchmarking study of top global innovators innovating for a green future based on 2.5 million patents that in one way or another contribute to the climate change mitigation technologies that are fundamental for moving towards a green future.

IAM is delighted to present the inaugural Patent Transactions, an online event designed to deliver a global overview of IP dealmaking, with a separate deep-dive focus on the Asia-Pacific market.

On 28 and 29 April, many of the world’s leading IP dealmakers will share best practices around buying, selling and licensing patents in the ever-changing global landscape.

Engage with key licensing decision makers, buyers and sellers from across the patent market and learn first-hand from their experience and insight.